Orbizol 200 mg/5 ml (Oral Suspension)

60 ml bottle: ৳ 25.00

Medicine Details

Category Details
Generic Metronidazole
Company Orbit pharmaceuticals ltd
Also available as

Title

Orbizol 200 mg/5 ml Suspension

Categories

  • Antibacterial
  • Antiprotozoal
  • Amoebicides
  • Anti-diarrhoeal

Description

Orbizol is indicated in the treatment and prevention of viral, parasitic, and bacterial infections such as trichomoniasis, septicaemia, bacteraemia, peritonitis, brain abscess, pelvic abscess, pelvic cellulitis, post-operative wound infections, urogenital trichomoniasis, bacterial vaginosis, amoebiasis, giardiasis, acute ulcerative gingivitis, anaerobically infected leg ulcers, pressure sores, acute dental infections, and antibiotic-associated pseudomembranous colitis.

DosageAndAdministration

  • TabletAndSuspension:
    • Trichomoniasis:
      • 200 mg tid or 400 mg bid for 7 days
      • 800 mg in the morning and 1-2 gm at night for 2 days
      • 2 gm as a single dose for 1 day
    • IntestinalAmoebiasis: 800 mg tid for 5 days
    • ExtraIntestinalAndAsymptomaticAmoebiasis: 400-800 mg tid for 5-10 days
    • Giardiasis: 2 gm once daily for 3 days
    • AcuteUlcerativeGingivitis: 200 mg tid for 3 days
    • BacterialVaginosis:
      • 400 mg bid for 7 days
      • 2 gm as a single dose for 1 day
    • LegUlcersAndPressureSores: 400 mg tid for 7 days
    • AnaerobicInfections: 800 mg initially and then 400 mg tid for 7 days
    • SurgicalProphylaxis: 400 mg tid started 24 hours before surgery for 1 day
  • VaginalGel: One applicator full intravaginally once or twice a day for 5 days
  • Suppository:
    • AnaerobicInfections:
      • Adults: 1 g every 8 hours for 3 days, then 1 g every 12 hours
      • Children: 5-10 years: 500 mg every 8 hours for 3 days, then every 12 hours; Over 10 years adult dose
    • SurgicalProphylaxis:
      • Adults: 1 g 2 hours before surgery; up to 3 further doses of 1 g may be given every 8 hours for high-risk procedures
      • Children: 5-10 years: 500 mg 2 hours before surgery; up to 3 further doses of 500 mg may be given every 8 hours for high-risk procedures
  • IVInfusion:
    • AdultsAndChildrenOver12Years: Infuse 500 mg 8 hourly at a rate of 5 ml/minute; maximum of 4 g should not be exceeded during a 24-hour period. Treatment for 7 days is sufficient for most patients, but treatment can be extended.

Interaction

  • Disulfiram: Psychotic reactions have been reported in patients using Orbizol and disulfiram concurrently.
  • Alcohol: Alcoholic beverages and drugs containing alcohol should not be consumed during therapy and for at least one day afterwards.
  • Lithium: Plasma levels of lithium may be increased by Orbizol.
  • Cyclosporin: Serum cyclosporin and serum creatinine should be closely monitored when co-administration is necessary.
  • Phenytoin or phenobarbital: increased elimination of Orbizol resulting in reduced plasma levels.
  • 5-Fluorouracil: Reduced clearance of 5-fluorouracil resulting in increased toxicity.
  • Busulfan: Plasma levels of busulfan may be increased by Orbizol, which may lead to severe busulfan toxicity.

Contraindications

Metronidazole is contraindicated in patients with a history of hypersensitivity to Metronidazole or other Nitroimidazole derivatives.

SideEffects

  • Metallic taste
  • Nausea
  • Vomiting
  • Diarrhoea
  • Drowsiness
  • Rashes

PregnancyAndLactation

US FDA Pregnancy Category of Metronidazole is B. Caution should be exercised when administered to a nursing woman.

PrecautionsAndWarnings

  • Hematological tests, especially leucocyte count should be carried out regularly for longer durations of administration
  • Administered with caution to patients with hepatic encephalopathy
  • May darken urine

UseInSpecialPopulations

  • HepaticImpairment: Administered with caution and dosage should be reduced in patients with hepatic encephalopathy
  • RenalImpairment: No routine adjustment in the dosage, efficiently removed during haemodialysis

OverdoseEffects

Single oral doses of Orbizol, up to 12 g have been reported in suicide attempts and accidental overdoses. Symptoms were limited to vomiting, ataxia, and slight disorientation.

TherapeuticClass

Amoebicides, Anti-diarrhoeal, Antiprotozoal

StorageConditions

Store below 30°C, protected from light, out of the reach of children, and not beyond the expiration date

CommonlyAskedQuestions

  • WhatIsOrbizolSuspension: An antibiotic medication for preventing the growth of bacteria and parasites
  • UsesOfOrbizolSuspension: Treatment and prevention from viral, parasitic and bacterial infections
  • SideEffectsOfOrbizolSuspension: Side effects such as diarrhoea, headache, weakness, painful urination, trouble sleeping, numbness, muscle weakness, and mouth ulcers

Related Brands